Comparison of cell-labeling methods with 124I-FIAU and 64Cu-PTSM for cell tracking using chronic myelogenous leukemia cells expressing HSV1-tk and firefly luciferase

Cancer Biotherapy and Radiopharmaceuticals

Volumn 27, Issue 10, 2012, Pages 719-728

  Park, Jae Jun ^a   Lee, Tae Sup ^a   Son, Jin Ju ^a   Chun, Kwon Soo ^a   Song, In Ho ^a,b   Park, Yong Serk ^b   Kim, Kwang Il ^a   Lee, Yong Jin ^a   Kang, Joo Hyun ^a  

^a Korea Institute of Radiation and Medical Science   (South Korea)

^b Yonsei University Wonju   (South Korea)

Author keywords

gene transfer; molecular imaging; PET

Indexed keywords

2' FLUORO 2' DEOXY 1 BETA DEXTRO ARABINOFURANOSYL 5 IODOURACIL I 124; FIREFLY LUCIFERASE; METHYLGLYOXAL BIS(4 METHYLTHIOSEMICARBAZONE) CU 64; RADIOPHARMACEUTICAL AGENT; THYMIDINE KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CELL LABELING; CELL TRACKING; CELL VIABILITY; CELLULAR DISTRIBUTION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; EX VIVO STUDY; FEMALE; GENETIC TRANSDUCTION; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; LUNG ALVEOLUS CELL; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ARABINOFURANOSYLURACIL; CELL TRACKING; COPPER RADIOISOTOPES; FEMALE; GENE TRANSFER TECHNIQUES; HERPESVIRUS 1, HUMAN; HUMANS; IODINE RADIOISOTOPES; K562 CELLS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LUCIFERASES, FIREFLY; MICE; MICE, INBRED BALB C; MICE, NUDE; ORGANOMETALLIC COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; THIOSEMICARBAZONES; THYMIDINE KINASE; TRANSPLANTATION, HETEROLOGOUS;

EID: 84870785782     PISSN: 10849785     EISSN: 15578852     Source Type: Journal    
DOI: 10.1089/cbr.2012.1225     Document Type: Article

References (36)

1. Akins EJ, Dubey P. Noninvasive imaging of cell-mediatedtherapy for treatment of cancer. J Nucl Med 2008;49 Suppl2:180S.
2. Kiessling F. Noninvasive cell tracking. Handb Exp Pharmacol2008;185 Pt 2:305.
3. Massoud TF, Gambhir SS. Molecular imaging in livingsubjects: Seeing fundamental biological processes in a newlight. Genes Dev 2003;17:545.
4. Lewin M, Carlesso N, Tung CH, et al. Tat peptidederivatizedmagnetic nanoparticles allow in vivo trackingand recovery of progenitor cells. Nat Biotechnol 2000;18:410.
5. Sutton EJ, Henning TD, Pichler BJ, et al. Cell tracking withoptical imaging. Eur Radiol 2008;18:2021.
6. Dobrenkov K, Olszewska M, Likar Y, et al. Monitoring theefficacy of adoptively transferred prostate cancer-targetedhuman T lymphocytes with PET and bioluminescence imaging.J Nucl Med 2008;49:1162.
7. Edinger M, Cao YA, Verneris MR, et al. Revealing lymphomagrowth and the efficacy of immune cell therapiesusing in vivo bioluminescence imaging. Blood 2003;101:640.
8. Edinger M, Hoffmann P, Contag CH, et al. Evaluation ofeffector cell fate and function by in vivo bioluminescenceimaging. Methods 2003;31:172.
9. Hardy J, Edinger M, Bachmann MH, et al. Bioluminescenceimaging of lymphocyte trafficking in vivo. Exp Hematol2001;29:1353.
10. Adonai N, Nguyen KN, Walsh J, et al. Ex vivo cell labelingwith 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone)for imaging cell trafficking in mice with positron-emissiontomography. Proc Natl Acad Sci USA 2002;99:3030.
11. Li ZB, Chen K, Wu Z, et al. 64Cu-labeled PEGylated polyethyleniminefor cell trafficking and tumor imaging. MolImaging Biol 2009;11:415.
12. Koehne G, Doubrovin M, Doubrovina E, et al. Serial in vivoimaging of the targeted migration of human HSV-TKtransducedantigen-specific lymphocytes. Nat Biotechnol2003;21:405.
13. Zanzonico P, Koehne G, Gallardo HF, et al. [131I]FIAU labelingof genetically transduced, tumor-reactive lymphocytes:Cell-level dosimetry and dose-dependent toxicity. EurJ Nucl Med Mol Imaging 2006;33:988.
14. Ponomarev V. Nuclear imaging of cancer cell therapies. JNucl Med 2009;50:1013.
15. Lucignani G, Ottobrini L, Martelli C, et al. Molecular imagingof cell-mediated cancer immunotherapy. Trends Biotechnol2006;24:410.
16. Blocklet D, Toungouz M, Kiss R, et al. 111In-oxine and 99mTc-HMPAO labelling of antigen-loaded dendritic cells: In vivoimaging and influence on motility and actin content. Eur JNucl Med Mol Imaging 2003;30:440.
17. Nayak TK, Brechbiel MW. Radioimmunoimaging with longer-lived positron-emitting radionuclides: Potentials andchallenges. Bioconjug Chem 2009;20:825.
18. Danos O, Mulligan RC. Safe and efficient generation of recombinantretroviruses with amphotropic and ecotropichost ranges. Proc Natl Acad Sci USA 1988;85:6460.
19. Doubrovin M, Ponomarev V, Beresten T, et al. Imagingtranscriptional regulation of p53-dependent genes withpositron emission tomography in vivo. Proc Natl Acad Sci US A 2001;98:9300.
20. Choi TH, Ahn SH, Kwon HC, et al. In vivo comparison ofIVDU and IVFRU in HSV1-TK gene expressing tumorbearing rats. Appl Radiat Isot 2004;60:15.
21. Kim JY, Park H, Lee JC, et al. A simple Cu-64 productionand its application of Cu-64 ATSM. Appl Radiat Isot 2009;67:1190.
22. Woo SK, Lee TS, Kim KM, et al. Anesthesia condition for18F-FDG imaging of lung metastasis tumors using smallanimalPET. Nucl Med Biol 2008;35:143.
23. Gambhir SS, Barrio JR, Wu L, et al. Imaging of adenoviraldirectedherpes simplex virus type 1 thymidine kinasereporter gene expression in mice with radiolabeled ganciclovir.J Nucl Med 1998;39:2003.
24. Laemmli UK. Cleavage of structural proteins during the assemblyof the head of bacteriophage T4. Nature 1970;227:680.
25. Tjuvajev JG, Avril N, Oku T, et al. Imaging herpes virusthymidine kinase gene transfer and expression by positronemission tomography. Cancer Res 1998;58:4333.
26. Tjuvajev JG, Finn R, Watanabe K, et al. Noninvasive imagingof herpes virus thymidine kinase gene transfer and expression:A potential method for monitoring clinical genetherapy. Cancer Res 1996;56:4087.
27. Brust P, Haubner R, Friedrich A, et al. Comparison of[18F]FHPG and [124/125I]FIAU for imaging herpes simplexvirus type 1 thymidine kinase gene expression. Eur J NuclMed 2001;28:721.
28. Haubner R, Avril N, Hantzopoulos PA, et al. In vivo imagingof herpes simplex virus type 1 thymidine kinase gene expression:Early kinetics of radiolabelled FIAU. Eur J NuclMed 2000;27:283.
29. Shields AF, Grierson JR, Kozawa SM, et al. Development oflabeled thymidine analogs for imaging tumor proliferation.Nucl Med Biol 1996;23:17.
30. Chou TC, Feinberg A, Grant AJ, et al. Pharmacological dispositionand metabolic fate of 2¢-fluoro-5-iodo-1-beta-Darabinofuranosylcytosinein mice and rats. Cancer Res1981;41:3336.
31. Tjuvajev JG, Doubrovin M, Akhurst T, et al. Comparison ofradiolabeled nucleoside probes (FIAU, FHBG, and FHPG)for PET imaging of HSV1-tk gene expression. J Nucl Med2002;43:1072.
32. Bennink RJ, Thurlings RM, van Hemert FJ, et al. Biodistributionand radiation dosimetry of 99mTc-HMPAO-labeledmonocytes in patients with rheumatoid arthritis. J Nucl Med2008;49:1380.
33. Botti C, Negri DR, Seregni E, et al. Comparison of threedifferent methods for radiolabelling human activated Tlymphocytes. Eur J Nucl Med 1997;24:497.
34. Huang J, Lee CC, Sutcliffe JL, et al. Radiolabeling rhesusmonkey CD34 + hematopoietic and mesenchymal stem cellswith 64Cu-pyruvaldehyde-bis(N4- methylthiosemicarbazone)for microPET imaging. Mol Imaging 2008;7:1.
35. Blower PJ, Lewis JS, Zweit J. Copper radionuclides and radiopharmaceuticalsin nuclear medicine. Nucl Med Biol1996;23:957.
36. Alauddin MM, Shahinian A, Park R, et al. In vivo evaluation of2¢-deoxy-2'-[18F]fluoro-5-iodo-1-beta-D-arabinofuranosyluracil([18F]FIAU) and 2¢-deoxy-2¢-[18F]fluoro-5-ethyl-1-beta-Darabinofuranosyluracil ([18F]FEAU) as markers for suicidegene expression. Eur J Nucl Med Mol Imaging 2007;34:822.